Skip to main content
logo
Dipna Pharmachem Limited (BOM:543594)
India flag India · Delayed Price · Currency is INR
4.170
-0.760 (-15.42%)
At close: Aug 4, 2026

Dipna Pharmachem Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,2911,2911,2491,643999.27727.55
Revenue Growth
21.07%3.33%-23.99%64.46%37.35%134.70%
Gross Profit
215.57215.57111.716444.3341.42
Operating Income
49.8349.8337.2734.2723.4121.7
Net Income
26.3226.329.7410.859.1211.67
Earnings Per Share
1.001.000.410.900.7669.46
EPS Growth
15.66%143.90%-54.44%18.42%-98.91%4721.77%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
11.9211.9211.08148.9459.42.09
Total Debt
132.11132.11172.23194.45159.08101.89
Net Cash (Debt)
-120.19-120.19-161.15-45.51-99.67-99.8
Net Cash Growth
------
Net Cash Per Share
-4.57-4.57-6.78-3.77-8.31-594.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-183.22-183.22-91.95-54.17-209.7628.05
Capital Expenditures
-0.41-0.41-0.2-0.15-0.1-0.07
Free Cash Flow
-183.63-183.63-92.15-54.31-209.8627.99
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
16.70%16.70%8.94%3.89%4.44%5.69%
Operating Margin
3.86%3.86%2.98%2.09%2.34%2.98%
Pretax Margin
2.75%2.75%1.14%0.86%1.38%2.16%
Profit Margin
2.04%2.04%0.78%0.66%0.91%1.60%
FCF Margin
-14.23%-14.23%-7.38%-3.31%-21.00%3.85%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
4.178.0135.3020.8716.47-
PS Ratio
0.080.160.280.140.15-